Clinical Trial Update: A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric Practices [Phase 3]

View source ↗

Summary

This Clinical Trial Update reports the completion of a Phase 3 study evaluating aripiprazole for schizophrenia and schizoaffective disorder in general psychiatr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Schizophrenia and Schizoaffective Disorder | Phase 3 | Status: COMPLETED